Dai Zijian, Yin Wanting, Li Jiahao, Ma Lingjun, Chen Fang, Shen Qun, Hu Xiaosong, Xue Yong, Ji Junfu
National Engineering and Technology Research Center for Fruits and Vegetables, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, P.R. China.
Biomater Res. 2025 Apr 28;29:0193. doi: 10.34133/bmr.0193. eCollection 2025.
Quercetin as a flavonoid polyphenol in nature has shown great anti-obesity effects. Due to its poor stability in chemical structure and low intestinal absorption, the in vivo bioavailability of quercetin is considered to be the main challenge for applications. To achieve the oral quercetin administration, chitosan was successfully trimethylated (TMC) to coat the quercetin-loaded zein nanoparticles (Zein-Q), which were designed as the core-shell structure for enhancing the intestinal absorption in this study. TMC-Zein-Q was demonstrated to protect quercetin from degradation and showed the sustained-release effect in an in vitro drug release experiment. The nanoparticles were found to reversibly open tight junctions between intestinal epithelial cells and help to increase quercetin uptake via the paracellular pathway in Caco-2 cells. In addition, the delivery system also showed stronger intestinal permeability and mucoadhesion in vivo, which improved the bioavailability of quercetin in cellular and animal experiments. After 10 weeks of intervention, TMC-Zein-Q could effectively suppress weight gain, improve serum lipid levels, and ameliorate hepatic steatosis and glucose tolerance in high-fat diet (HFD) mice by mediating the AMPK pathway. Consequently, this work successfully constructed TMC-Zein-Q for oral quercetin delivery, providing a novel and feasible strategy for the treatment of obesity via the oral route.
槲皮素作为一种天然存在的黄酮类多酚,已显示出强大的抗肥胖作用。由于其化学结构稳定性差且肠道吸收低,槲皮素的体内生物利用度被认为是其应用的主要挑战。为实现槲皮素的口服给药,壳聚糖成功进行了三甲基化修饰(TMC)以包覆负载槲皮素的玉米醇溶蛋白纳米粒(Zein-Q),在本研究中其被设计为核壳结构以增强肠道吸收。在体外药物释放实验中,TMC-Zein-Q被证明可保护槲皮素不被降解并呈现出缓释效果。研究发现,纳米粒可使肠上皮细胞间的紧密连接可逆性开放,并有助于通过Caco-2细胞中的细胞旁途径增加槲皮素的摄取。此外,该递送系统在体内还表现出更强的肠道通透性和黏膜黏附性,这在细胞和动物实验中提高了槲皮素的生物利用度。经过10周的干预,TMC-Zein-Q可通过介导AMPK途径有效抑制高脂饮食(HFD)小鼠的体重增加、改善血脂水平,并减轻肝脂肪变性和葡萄糖耐量。因此,本研究成功构建了用于口服递送槲皮素的TMC-Zein-Q,为通过口服途径治疗肥胖提供了一种新颖且可行的策略。